A deep discussion of cutting-edge medical interventions for slowing or reversing aging and their potential clinical implications.
Key Takeaways
- Many cutting-edge anti-aging interventions are not FDA-approved and require medical supervision
- Peptides such as MOTS-c and Humanin improved metabolic health and physical decline in mice
- Cellular reprogramming and stem cell therapies show promise for resetting biological age